RhoA inhibitors (Alseres)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRhoA inhibitors (Alseres)
Drug Alias NameALSE-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming protein RhoA inhibitors
TargetsTransforming protein RhoA
Therapy Area/IndicationsCardiomyopathiesEye DiseasesCentral Nervous System Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlseres Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlseres Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCardiomyopathiesEye DiseasesCentral Nervous System Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A